Trademark: 97761200
Word
ETIL
Status
Pending
Status Code
661
Status Date
Thursday, April 25, 2024
Serial Number
97761200
Mark Type
4
Filing Date
Thursday, January 19, 2023

Trademark Owner History

Classifications
5 Pharmaceuticals comprised of engineered cells for the treatment of cancer, infectious diseases, and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, renal, pulmonary, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, inflammatory, and autoimmune related diseases and disorders

Trademark Events
Jan 23, 2023
New Application Entered
Feb 9, 2023
New Application Office Supplied Data Entered
Oct 17, 2023
Assigned To Examiner
Oct 18, 2023
Non-Final Action Written
Oct 18, 2023
Non-Final Action E-Mailed
Oct 18, 2023
Notification Of Non-Final Action E-Mailed
Dec 19, 2023
Teas Response To Office Action Received
Dec 19, 2023
Correspondence Received In Law Office
Dec 19, 2023
Teas/Email Correspondence Entered
Jan 29, 2024
Non-Final Action Written
Jan 29, 2024
Non-Final Action E-Mailed
Jan 29, 2024
Notification Of Non-Final Action E-Mailed
Apr 24, 2024
Correspondence Received In Law Office
Apr 24, 2024
Teas Response To Office Action Received
Apr 25, 2024
Teas/Email Correspondence Entered

Trademark Alertz updated from USPTO on 2030-01-24